Gly-Sal 2-2 Pads

Description

REPLENiX® ACNE SOLUTIONS, manufactured by Topix Pharmaceuticals, Inc., is presented in the form of Gly/Sal® 2-2 Pads. Each pad contains 2% Glycolic Acid and 2% Salicylic Acid USP, formulated to address acne-related concerns. The product is packaged in a container containing 60 pads, designed for topical application.

Uses and Indications

This drug is indicated for the treatment of acne through the use of cleansing pads. There are no teratogenic or nonteratogenic effects associated with this product, making it suitable for use without specific concerns regarding these effects.

Dosage and Administration

The affected area should be wiped with a pad one to three times daily. It is recommended to initiate treatment with one application per day to minimize the risk of excessive skin drying. Based on the patient's response and as directed by a physician, the frequency may be gradually increased to two or three times daily.

In cases where bothersome dryness or peeling occurs, the application frequency should be reduced to once daily or every other day to alleviate these symptoms. Careful monitoring of the skin's response is advised to ensure optimal treatment outcomes.

Contraindications

Use of this product is contraindicated in the following situations:

Discontinue use and consult a healthcare professional if irritation develops. Concurrent use of other topical acne medications may exacerbate skin dryness or irritation; therefore, only one medication should be utilized unless directed by a healthcare provider. In the event of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately.

Warnings and Precautions

This product is intended for external use only. It is imperative to avoid contact with the eyes, lips, and mouth to prevent irritation or adverse reactions. To ensure safety, the product should be kept out of reach of children.

In the event that skin irritation develops, it is advised to discontinue use immediately and consult a healthcare professional for further guidance. Caution is warranted when using this product in conjunction with other topical acne medications, as simultaneous use may exacerbate dryness or irritation of the skin. If such reactions occur, it is recommended to limit the use to one medication unless otherwise directed by a healthcare provider.

In case of accidental ingestion, it is crucial to seek professional medical assistance or contact a Poison Control Center without delay.

Additionally, the use of sunscreen is strongly recommended when using this product, particularly those containing glycolic acid, and for at least one week following its use. This precaution is necessary as some individuals may exhibit increased sensitivity to sunlight. Regular monitoring of skin condition and sensitivity is advised to ensure safe and effective use.

Side Effects

Patients using this product should be aware that it is for external use only and must be kept away from the eyes, lips, and mouth. In clinical practice, if irritation develops, it is advised to discontinue use and consult a healthcare professional.

The concurrent use of other topical acne medications may exacerbate dryness or irritation of the skin. In such cases, it is recommended that only one medication be used unless otherwise directed by a physician.

In the event of accidental ingestion, patients should seek professional assistance or contact a Poison Control Center immediately. Additionally, the use of sunscreen is recommended while using this product and for at least one week thereafter, as some individuals may exhibit increased sensitivity to sunlight.

Drug Interactions

Concurrent use of other topical acne medications with this product may lead to increased dryness or irritation of the skin. In such cases, it is advisable to limit the use to one medication at a time unless otherwise directed by a healthcare professional. Monitoring for signs of excessive dryness or irritation is recommended to ensure patient comfort and skin health.

Packaging & NDC

Below are the non-prescription pack sizes of Gly-Sal 2-2 Pads (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event that irritation develops, it is recommended to discontinue use and consult a healthcare professional.

Geriatric Use

There is no specific information regarding the use of Gly-Sal 2-2 Pads in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this product to elderly patients, as the absence of data necessitates careful consideration of individual patient factors and potential risks. Monitoring for any adverse effects or unusual responses in this population is advisable, given the lack of established guidelines for geriatric use.

Pregnancy

The safety of Gly-Sal 2-2 Pads during pregnancy has not been established. The use of this product is not recommended during pregnancy due to potential risks to the fetus. Pregnant patients or those planning to become pregnant should consult a healthcare provider before using this product to discuss any potential risks and benefits.

Lactation

There are no specific warnings or recommendations regarding the use of Gly-Sal 2-2 Pads in lactating mothers. Additionally, there are no specific considerations or precautions related to lactation mentioned in the provided text.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the patient's overall health status and liver function.

Overdosage

In the event of an overdosage, it is imperative that healthcare professionals take immediate action. If the substance is ingested, it is crucial to seek professional assistance without delay. Contacting a Poison Control Center is strongly recommended to ensure appropriate management and guidance.

Healthcare providers should be vigilant for potential symptoms associated with overdosage, which may vary depending on the specific substance involved. Prompt recognition of these symptoms is essential for effective intervention.

Management of overdosage should be guided by the severity of symptoms and the specific circumstances of the case. Continuous monitoring and supportive care may be necessary, and healthcare professionals should follow established protocols for the treatment of overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion. Patients should be informed that if irritation develops during use, they should discontinue the product and consult a doctor for further guidance.

It is important to discuss the potential for increased dryness or irritation if patients are using other topical acne medications concurrently or immediately after applying this product. Patients should be instructed to use only one medication at a time unless otherwise directed by a healthcare professional.

In the event of accidental ingestion, patients should seek professional assistance or contact a Poison Control Center immediately. Additionally, healthcare providers should recommend the use of sunscreen while using this product and for at least one week thereafter, as some individuals may experience heightened sensitivity to sunlight.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light to prevent degradation. After opening, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with patients advised to wipe the entire affected area with a pad one to three times daily. Clinicians should counsel patients on the importance of using sunscreen while using any glycolic acid product and for an additional week thereafter, as some individuals may exhibit increased sensitivity to sunlight.

No further information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Gly-Sal 2-2 Pads, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)